GlobeNewswire 4/25/2024 deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ...
GlobeNewswire 4/24/2024 QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and comba...
GlobeNewswire 4/18/2024 deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing...
GlobeNewswire 4/9/2024 QIAGEN N.V. to release results for Q1 2024 and hold webcast
GlobeNewswire 4/3/2024 QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Ann...
GlobeNewswire 3/25/2024 QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration a...
GlobeNewswire 3/18/2024 QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosi...
GlobeNewswire 3/11/2024 QIAGEN announces Form 20-F annual report filing for 2023 results
GlobeNewswire 2/27/2024 QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery
GlobeNewswire 2/27/2024 QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Plati...
GlobeNewswire 2/15/2024 QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Plati...
GlobeNewswire 2/6/2024 QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved op...
TeleTrader 2/6/2024 Europe higher at close, economic prints in spotlight
TeleTrader 1/29/2024 Europe opens mixed ahead of data
GlobeNewswire 1/25/2024 QIAGEN announces partnership with Penn State University to advance microbiome sciences
GlobeNewswire 1/18/2024 QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 mi...
GlobeNewswire 1/11/2024 QIAGEN N.V. to release results for Q4 2023 and hold webcast
GlobeNewswire 1/8/2024 QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Sy...
GlobeNewswire 1/7/2024 QIAGEN announces plans to return approximately $300 million to shareholders
GlobeNewswire 1/4/2024 QIAGEN to accelerate investments into QIAGEN Digital Insights bioinformatics business
GlobeNewswire 1/3/2024 QIAGEN expands business in Middle East with new regional headquarters and major projects
GlobeNewswire 11/30/2023 DNA Labs International solves significant cold cases with QIAGEN workflow for forensic genetic genea...
GlobeNewswire 11/15/2023 QIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro Kit for improved sample processing and ...
GlobeNewswire 11/9/2023 QIAGEN launches new QIAcuity digital PCR kits and updated software to expand use by biopharma and fo...
GlobeNewswire 11/6/2023 QIAGEN launches complete Sample to Insight workflow for microbiome research